In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  warfarin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CCCWFU-97194, NCI-P95-0064

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 to 69
Sponsor: NCI
Protocol IDs: CLB-8084, CALGB-8084

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GI-82351

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: EORTC-19793, UKM-HH-1

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-8534, CALGB-8534

6.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: IN 0901 INT, 2009-018141-20, NCT01130025

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 21
Sponsor: NCI
Protocol IDs: CLB-8532, CALGB-8532

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-026-202, RPMI-PPC-580

9.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 00-113, MSKCC-00113, NCI-G01-1927, NCT00014352

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: DMS-8308, NCI-V87-0190

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000386239, P30CA016042, UCLA-0403067-01, NOVARTIS-CPTK7870113, NCT00091299

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CEPO906A2120, NCT00448396

13.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22676, NCT01001299

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12434, NCT01287598

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PXD101-CLN-20, NCT01317927

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9763, H6Q-MC-JCAX, NCT01388335

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U158, NCT01517399

18.

Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CRC-WARP, EU-20049, NCT00024297

19.

Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: FCCC-87885, NCI-V87-0299
New Search